SecBot SecBot
EFFECT ·Filed Mar 20, 2026

APRE

Aprea Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed7mo ago SEC9999999995-26-000871
IPO/offering going effective
Actionable Insight • Neutral

Monitor for future 8-K filings or prospectus supplements that may announce actual offerings under this shelf; watch for insider selling or accelerated financings given the small market cap ($9M)

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
APRE ▼ -8.27% at T+60d
NEUTRAL call -8.27% · α vs SPY -22.69% · entry $0.7620 → $0.6990
Entry = T+0 close
Mar 20, 2026
via day close
T+1d
-10.50%
call -10.50% · α -11.60%
$0.6820
settled 7mo ago
T+5d
-10.37%
call -10.37% · α -8.22%
$0.6830
settled 7mo ago
T+20d
+28.74%
call +28.74% · α +19.42%
$0.9810
settled 6mo ago
T+60d
-8.27%
call -8.27% · α -22.69%
$0.6990
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Aprea Therapeutics' shelf registration (Form S-3) has become effective, allowing the company to issue unspecified securities from time to time. This creates a potential dilution overhang but provides flexibility for future capital raising.

Key Facts

  • Form S-3 shelf registration (File No. 333-293609) became effective on March 19, 2026
  • Company can now issue unspecified amounts of securities at its discretion
  • No immediate offering size, pricing, or use of proceeds disclosed
  • Filing allows for at-the-market (ATM) offerings or other financing methods

Financial Impact

Potential future dilution depending on offering size and timing; no specific dollar amount or share count disclosed

dilutionequitymarketCap

Risk Factors

  • Potential for significant dilution if the company issues a large number of shares
  • Financing could occur at a discount to current market price, negatively impacting shareholders

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000871
Document: 9999999995-26-000871-index.html9999999995-26-000871
Document: 9999999995-26-000871.txt9999999995-26-000871
12 reports for APRE
Performance horizon
50% Hit rate @ T+60 3 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +24.32%Apr 22, 2026
Filters
Rows
Reports for APRE — sortable, filterable
TypeNow
Aug 28, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$0.8386awaiting T+60—$0.5180 (−38.23%)
Aug 12, 2026
10w ago
8-K
NEUTRAL ★ 5/10
$0.6830awaiting T+60—$0.5180 (−24.16%)
Aug 12, 2026
10w ago
Press Release
NEUTRAL ★ 5/10
$0.6830awaiting T+60—$0.5180 (−24.16%)
May 13, 2026
23w ago
8-K
BULLISH ★ 7/10
$0.8800 $0.6503▼ −26.10%▼ −30.54%$0.5180 (−41.14%)
May 13, 2026
23w ago
Press Release
NEUTRAL ★ 5/10
$0.8800 $0.6503▼ −26.10%▼ −30.54%$0.5180 (−41.14%)
Apr 30, 2026
25w ago
DEFA14A
BEARISH ★ 7/10
$0.8000 $0.6247▲ +21.91%▲ +25.02%$0.5180 (+35.25%)
Apr 22, 2026
26w ago
S-3
BEARISH ★ 7/10
$0.8840 $0.6690▲ +24.32%▲ +29.34%$0.5180 (+41.40%)
Apr 21, 2026
26w ago
Press Release
BULLISH ★ 7/10
$0.9070 $0.6900▼ −23.93%▼ −30.82%$0.5180 (−42.89%)
Mar 31, 2026
29w ago
Insider Cluster
BULLISH ★ 6/10
$0.7630 $0.7900▲ +3.54%▼ −8.84%$0.5180 (−32.11%)
Mar 20, 2026
31w ago
EFFECT
NEUTRAL ★ 4/10
$0.7620 $0.6990▼ −8.27%▼ −22.69%$0.5180 (−32.02%)
Showing 10 of 12

US Market Status

Market Closed — Opens in 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 20, 2026